Selenium Preclinical Studies of Anticancer Therapeutic Potential
Abstract
Selenium is a trace element that is essential to the human diet. Deficiency states have been described in both animals and humans. In addition, selenium compounds have demonstrated toxicity in humans, as well as in human tissues in culture. As early as 1956, one form of selenium was used as an antineoplastic agent in humans with some demonstrated activity. Recently, evidence in both tumor-bearing animals and human tumor cells in culture have confirmed an antitumor effect of potential clinical benefit. The mechanism of this cy-toxic effect appears, at least in part, to relate to the property of some forms of selenium to oxidize critical sulfhydral groups in the cell. Evidence for this, and the resulting implications for the use of selenium in anticancer treatment, is presented in this manuscript.
Index Entries
Selenium, as antineoplastic agent selenium, as antitumor agentPreview
Unable to display preview. Download preview PDF.
References
- 1.R. Lotan, G. Dennert, Cancer Res. 39, 55, 1979.PubMedGoogle Scholar
- 2.D. N. Carney, P. A. Bunn, A. F. Gazdar, et al, Proc. Natl. Acad. Sci. 78, 3185, 1981.PubMedCrossRefGoogle Scholar
- 3.G. Batist, A. G. Katki, R. W. Klecker, and C. E. Myers, Cancer Res. 46, 5482, 1986.PubMedGoogle Scholar
- 4.A. M. Watrach, J. A. Milner, M. A. Watrach, and K. A. Poirier, Cancer Lett. 25, 41, 1984.PubMedCrossRefGoogle Scholar
- 5.M. E. Fico, K. A. Poirier, A. M. Watrach, et al., Cancer Res. 46, 3384, 1986.PubMedGoogle Scholar
- 6.C. C. Tsen and A. L. Tappel, J. Biol. Chem. 233, 1230, 1958.PubMedGoogle Scholar
- 7.I. Rosenfield and O. A. Beath, J. Biol. Chem. 220, 333, 1947.Google Scholar
- 8.H. E. Ganthier, BioChem. 10, 4089, 1971.CrossRefGoogle Scholar
- 9.K. A. Poirier and J. A. Milner, J. Nutr. 113, 2147, 1983.PubMedGoogle Scholar
- 10.B. A. Arrick and C. F. Nathon, Cancer Res. 44, 4224, 1984.PubMedGoogle Scholar
- 11.A. Stahl, I. Anundi, and J. Hogberg, Biochem. Pharm. 33, 1111, 1984.PubMedCrossRefGoogle Scholar
- 12.I. Anundi, A. Stahl, and J. Hogberg, Chem-Biochem. Int. 50, 277, 1984.Google Scholar
- 13.P. Delbet, Bull. Assoc. Franc. Etud. Cancer 5, 121, 1912.Google Scholar
- 14.A. T. Todd, S. G. Scott, and H. Coke, Proc. Roy. Soc. Med. 28, 681, 1935.Google Scholar
- 15.C. H. Walker and F. Klein, Am. Med. 21, 628, 1915.Google Scholar
- 16.G. B. Abdullaev, G. G. Gasanov, R. N. Ragimov, G. V. Teplyakova, et al., Dokl. Acad. Nduk. Azerb. SSR 29, 18, 1973.Google Scholar
- 17.A. S. Weisberger and L. G. Suhrland, Blood 11, 1956.Google Scholar
- 18.T. C. Hamilton, C. Winkler, K. Lonic, et al. Biochem. Pharm. 34, 2583, 1985.PubMedCrossRefGoogle Scholar
- 19.G. Batist, A. Tulpule, B. K. Sinha, et al., J. Biol. Chem. 261, 15544, 1986.PubMedGoogle Scholar
- 20.G. C. Yeh, S. J. Occhipinti, J. M. Phang, et al., Proc. Am. Assoc. Can. Res. 1075, 271, 1986.Google Scholar
- 21.J. R. Babson, N. S. Abell, and D. J. Reed, Biochem. Pharm. 30, 2299, 1981.PubMedCrossRefGoogle Scholar